The discipline was the whole identity. For more than twenty years Benchmark kept its funds around $425m and backed only young companies, taking a roughly 20% stake in each and trusting that selectivity, not scale, would produce the returns. That model has now bent.
The firm has closed $2bn across two new funds, according to the Wall Street Journal, including a $1.25bn vehicle dedicated to later-stage investments, the first growth fund in its history.
Alongside the $1.25bn growth fund sits a $750m early-stage vehicle, larger than the funds Benchmark has historically raised and a concession that even seed and Series A cheques now have to be bigger to compete. The firm that defined itself by staying small has decided that staying small had become a constraint.
It is not hard to see what the constraint cost. Benchmark’s fund sizes likely kept it out of the capital-intensive AI labs, where rounds run into the hundreds of millions; the firm never invested in OpenAI, Anthropic, or the wave of foundation-model start-ups that have defined the cycle. Where it did place AI bets, results were mixed.
Benchmark led a $75m round in Manus, a Singapore-based agent platform that reached $100m in annual recurring revenue within eight months, and watched Meta agree to buy it for roughly $2bn, only for Chinese regulators to block the deal in April over export-control law, leaving the stake in limbo.
